Sonnet BioTherapeutics Holdings, Inc. (SONN)

SONN Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	3.79	2.27	3.05	27.62	7.35	0.04
Cash & Cash Equivalents	3.79	2.27	3.05	27.62	7.35	0.04
Cash Growth	-66.76%	-25.50%	-88.95%	275.82%	20515.10%	-93.20%
Other Current Assets	1.44	2.46	2.36	1.19	0.29	0
Total Current Assets	5.22	4.74	5.41	28.81	7.64	0.04
Property, Plant & Equipment	0.19	0.23	0.3	0.18	0.27	0
Other Long-Term Assets	0.5	0.46	0.11	0	0.08	0
Total Long-Term Assets	0.69	0.69	0.42	0.18	0.36	0
Total Assets	5.91	5.43	5.83	28.99	7.99	0.04
Accounts Payable	1.75	2.2	4.75	3.78	2.06	1.84
Deferred Revenue	0	0.02	0.17	0.52	0.5	0
Current Debt	0.08	0.07	0.05	0.1	0.1	0.22
Other Current Liabilities	0.93	3.23	3.19	2.31	2.06	0.82
Total Current Liabilities	2.76	5.52	8.16	6.7	4.72	2.89
Long-Term Debt	0.09	0.13	0.2	0.03	0.25	0
Total Long-Term Liabilities	0.09	0.13	0.2	0.03	0.25	0
Total Liabilities	2.86	5.66	8.37	6.73	4.97	2.89
Total Debt	0.17	0.2	0.26	0.13	0.35	0.22
Debt Growth	-28.90%	-20.34%	103.36%	-64.37%	62.51%	-97.75%
Retained Earnings	-111.05	-110.24	-91.41	-61.69	-36.71	-12.44
Shareholders' Equity	3.05	-0.23	-2.54	22.26	3.02	-2.85
Net Cash / Debt	3.62	2.07	2.8	27.5	7	-0.18
Net Cash / Debt Growth	-67.57%	-25.98%	-89.83%	292.99%	-	-
Net Cash Per Share	0.74	1.99	14.16	345.00	228.75	-10.47
Working Capital	2.46	-0.79	-2.75	22.11	2.91	-2.85
Book Value Per Share	0.66	-0.22	-12.86	279.30	98.73	-163.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).